SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


National Association for Continuing Education
Speaker
Birgit Amann, MD
Medical Director/Founder
Behavioral Medical Center - Troy
Troy, MI

Moderator
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Title
: Bringing ADHD into Focus: Strategies for Individualizing Care
Activity/Course #:
: NCME386
Cost:
: Free
Release/Start Date:
: Jul 30 2019
Expiration Date:
: Jul 29 2020
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers, Psychiatry
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.50 pharmacology hour(s)
Hardware/Software Requirements:
Program Summary
Once thought of as a childhood disorder that primarily affected “disruptive” boys, ADHD is now known to persist into adulthood in approximately 60% of cases with an overall prevalence of 3-4% of US adults. Adult ADHD has a severe impact on patients and families, but the condition remains underrecognized and undertreated. This activity will review the pervasive nature of ADHD and its associated morbidity and mortality, the tools to aid in diagnosis, and examine individualized treatment regimens for patients with ADHD.

This webcast was recorded live at the Emerging Challenges in Primary Care 2019 Live Virtual Symposium and is being used with the permission of the presenters.

Learning Objectives
 
After completing this program participants should be able to:
  1. Recognize the pervasive nature and global impact of ADHD symptoms throughout the day
  2. Describe the physical and psychologic morbidity and mortality associated with ADHD
  3. Use ADHD assessment tools to aid in diagnosis, track, and measure changes in ADHD symptoms to optimize pharmacologic treatment, non-pharmacologic treatment, and symptom control throughout the day
  4. Implement appropriate and individualized treatment regimens for patients with ADHD
How to obtain the CME Certificate
  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1 contact hour of continuing education which includes 0.50 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. All planners are also required to disclose all relevant financial relationships. Disclosure information is provided below.

Speaker
Birgit Amann, MD serves as a speaker/consultant for Tris, Neos, Rhodes, Purdue, Shire, Supernus, Akili, Otsuka, Takeda-Lundbeck, and Ironshore.

Contributing Faculty
Greg Mattingly, MD serves as a speaker for Allergan, Alkermes, Lundbeck, Neos, Otsuka, Shire, Sunovion, and Takeda. He has also served as a consultant for Allergan, Alkermes, Intra-Cellular Therapies, Lundbeck, Otsuka, Perdue, Rhodes, Shire, Sunovion, Supernus, and Takeda. He has also done research for Akili, Allergan, Axsome, Alkermes, Boehringer Ingelheim, Janssen, Medgenics, NLS-1 Pharma AG, Sage, Shire, Sunovion, Supernus, and Takeda.

C. Brendan Montano, MD serves on the advisory board and research grant committee for Sunovion and on the research grant committee for Axsome Therapeutics, Arbor Pharmaceuticals, Sage Therapeutics, Avanir Pharmaceuticals, Tonix Pharmaceuticals, and Sanofi Pharmaceuticals.

Activity Planning Committee
Gregg Sherman, MD, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Daniela Hiedra, BA, has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from Shire.